期刊文献+

味精减少食品中钠含量作用的探讨 被引量:11

Effect of Monosodium Glutamate on the Reduction of Sodium in Food
下载PDF
导出
摘要 氯化钠(NaCl)是用于增加食品咸味最常用的成分,但血液中过量的钠会导致一些慢性非传染性疾病的发展。为了将钠摄入量限制在安全的水平,世界卫生组织(WHO)建议每天摄入NaCl的量不超过5g(即钠的摄入量少于2g)。因此,当前迫切需要寻找盐替代品,鲜味化合物L-谷氨酸钠(MSG)是很好的替代物。科学委员会和监管机构对MSG作为食品添加剂的毒性问题进行了一系列评估。对咸味和鲜味进行了生理学阐述,介绍了MSG在降低特定预包装食品中钠含量的潜在应用以及作为食品添加剂方面的安全性问题。 Sodium chloride(NaCl)is the most commonly used ingredient to provide salty taste in foods.However,excess sodium in the bloodstream has been associated with the development of several chronic non-communicable diseases.In order to limit sodium intake to levels considered safe,the World Health Organization(WHO)recommends for adults a daily intake of no more than 5 g of NaCl(less than 2 g sodium).This recommendation indicates that there is an urgent need to find salt substitutes,and umami compounds have been pointed as an alternative strategy and the umami compound sodium glutamate(MSG)is a good substitute.The toxicity of MSG as a food additive has been evaluated by scientific committees and regulatory agencies.In this paper,an overview about salty and umami taste physiology,the potential application of MSG to reduce sodium content in specific industrialized foods and safety aspects of MSG as food additive are presented.
作者 姜巍伟 彭伟 赵媛媛 JIANG Wei-wei;PENG Wei;ZHAO Yuan-yuan(Qingdao University of Science and Technology,Qingdao 266042,China)
机构地区 青岛科技大学
出处 《中国调味品》 CAS 北大核心 2018年第10期181-184,200,共5页 China Condiment
基金 国家自然科学基金项目(21576145) 山东省自然科学基金项目(ZR2017MB065)
关键词 L-谷氨酸钠 咸味 氯化钠 鲜味 L-sodium glutamate salty taste sodium chloride umami
  • 相关文献

参考文献3

二级参考文献77

  • 1中国的包装食品[J].中国食品工业,2006(2):51-51. 被引量:1
  • 2王陇德.2002中国居民营养与健康状况调查报告之一[M].北京:人民卫生出版社,2005.
  • 3EOIN D. Reducing salt: a challenge for meat industry[J]. Meat Science, 2006, 74(1): 188-196.
  • 4TIM H. Technological functions of salt in the manufacturing of food and drink productions[J]. British Food Journal, 2002, 104(2): 126-152.
  • 5Intersalt Cooperative Research Group. Intersalt: an international study of eleclrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion[J]. British Medical Journal, 1988, 297: 319-328.
  • 6HE F J, MACGREGOR G A. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes[J]. J Hum Hypertens, 2009, 23(6): 363-384.
  • 7COOK N R, CUTLER J A, OBARZANEK E, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes:observational follow-up of the trials of hypertension prevention(TOHP)[J]. British Medical Journal, 2007, 334: 885-888.
  • 8TUOMILEHTO J, JOUSILAHTI P, RASTENYTE D, et al. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study[J]. Lancet, 2001, 357:848-851.
  • 9CIANCIARUSO B, BELLIZZI V, MINUTOLO R, et al. Salt intake and renal outcome in patients with progressive renal disease[J]. Miner Electrolyte Metab, 1998, 24(4): 296-301.
  • 10SWIFT P A, MARKANDU N D, SAGNELLA GA, etaL Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: arandomized coatrol trial[J]. Hypertension, 2005, 46(2): 308-312.

共引文献67

同被引文献83

引证文献11

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部